Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FEXQ7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,231
Award facts
- Contract value 100% obligated
- $23,230.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,230.67 delivery order to AmerisourceBergen Drug Corp for Wegovy (semaglutide) 1 mg/0.5 mL pens on July 14, 2025, with a completion date of July 15, 2025. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal medical procurement requirements through open competition with the Defense Logistics Agency and serves critical healthcare needs for military, veteran, and other federal healthcare systems. The SPE2DX IDC encompasses a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Wegovy reflects the company's role in supporting diabetes and metabolic health treatment requirements within the federal health system.
Quick answers
Who was awarded contract SPE2DB25FEXQ7?
SPE2DB25FEXQ7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FEXQ7 worth?
The government has obligated $23,231 on SPE2DB25FEXQ7.
Is contract SPE2DB25FEXQ7 an order under another contract?
Yes. SPE2DB25FEXQ7 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FEXQ7 competed?
The extent of competition for SPE2DB25FEXQ7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award